HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiang-Yang Lu Selected Research

3,4,5,6-tetrahydroxyxanthone

12/2008Beneficial effect of 3,4,5,6-tetrahydroxyxanthone on dyslipidemia in apolipoprotein E-deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiang-Yang Lu Research Topics

Disease

4Atherosclerosis
06/2017 - 12/2008
2Obesity
08/2018 - 01/2018
2Body Weight (Weight, Body)
08/2018 - 01/2018
2Necrosis
06/2018 - 01/2018
1Sleep Wake Disorders
09/2018
1Sleep Deprivation
09/2018
1Mastitis
06/2018
1Endometritis
02/2018
1Acidosis
12/2017
1Pathologic Processes
12/2017
1Osteoporosis
01/2014
1Inflammation (Inflammations)
01/2014
1Pain (Aches)
01/2014
1Hyperlipidemias (Hyperlipidemia)
12/2013
1Dyslipidemias (Dyslipidemia)
12/2008
1Neoplasms (Cancer)
09/2006

Drug/Important Bio-Agent (IBA)

4Apolipoproteins E (ApoE)IBA
06/2017 - 12/2008
4ApolipoproteinsIBA
06/2017 - 12/2008
28-epi-prostaglandin F2alphaIBA
09/2018 - 02/2018
2kaempferolIBA
06/2018 - 12/2011
2CholesterolIBA
01/2018 - 06/2017
2Triglycerides (Triacylglycerol)IBA
01/2018 - 06/2017
2Ion Channels (Ion Channel)IBA
12/2017 - 01/2014
2Angiopoietin-Like Protein 3IBA
12/2013 - 12/2008
1AcidsIBA
09/2018
1Norepinephrine (Noradrenaline)FDA LinkGeneric
09/2018
1dimethylargininaseIBA
09/2018
1Hypnotics and Sedatives (Sedatives)IBA
09/2018
1Glutamic Acid (Glutamate)FDA Link
09/2018
1Adenosine Monophosphate (AMP)IBA
08/2018
1naringinIBA
08/2018
1Proprotein Convertase 9IBA
08/2018
1Sterol Regulatory Element Binding ProteinsIBA
08/2018
1LDL Receptors (LDL Receptor)IBA
08/2018
1GlycosidesIBA
08/2018
1Protein Kinases (Protein Kinase)IBA
08/2018
1InterleukinsIBA
06/2018
1Peroxidase (Myeloperoxidase)IBA
06/2018
1Angiopoietin-Like Protein 2IBA
06/2018
1Interleukin-6 (Interleukin 6)IBA
02/2018
1LipidsIBA
01/2018
1phillyrinIBA
01/2018
1Angiopoietin-Like Protein 4IBA
01/2018
1Nonesterified Fatty Acids (NEFA)IBA
01/2018
1GlucosidesIBA
01/2018
1Insulin (Novolin)FDA Link
01/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018
1LeptinIBA
01/2018
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2018
1PPAR-betaIBA
01/2018
1AMP-Activated Protein KinasesIBA
01/2018
1Epithelial Sodium ChannelsIBA
12/2017
1Degenerin Sodium ChannelsIBA
12/2017
12-guanidine-4-methylquinazolineIBA
12/2017
1Acid Sensing Ion ChannelsIBA
12/2017
1icariinIBA
06/2017
1Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2017
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
06/2017
1Adenosine Triphosphate (ATP)IBA
01/2014
1Lipase (Acid Lipase)FDA Link
12/2013
1CytokinesIBA
12/2011
1FlavonoidsIBA
12/2011
1OsteopontinIBA
12/2011
1N,N-dimethylarginine (asymmetric dimethylarginine)IBA
07/2009
1xanthoneIBA
12/2008
13,4,5,6-tetrahydroxyxanthoneIBA
12/2008
1RNA (Ribonucleic Acid)IBA
09/2006
1Small Interfering RNA (siRNA)IBA
09/2006
1Catalytic RNA (Ribozymes)IBA
09/2006
1Antisense RNA (Anti-Sense RNA)IBA
09/2006

Therapy/Procedure

2Aftercare (After-Treatment)
09/2018 - 01/2018